New Morning Sickness Drug OKd

Wednesday, 10 Apr 2013 05:50 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
Diclegis (doxylamine succinate and pyridoxine hydrochloride) has been approved by the FDA to treat nausea and vomiting associated with morning sickness during pregnancy.
The drug was sanctioned for pregnant women who haven't responded to other therapies, such as eating smaller meals, eating lower-fat foods, and avoiding smells that can prompt nausea.
Diclegis was evaluated in 261 adult women with morning sickness who had been pregnant between seven and 14 weeks. Women who took the drug had less nausea and vomiting than those who took a placebo. Studies also showed the drug didn't pose a threat to the fetus.
The most common side effect of the drug -- with a typical once-daily dose of two pills -- was potentially severe drowsiness. Women who take Diclegis should avoid driving or operating heavy machinery, the agency said.
The drug is marketed by the Canadian pharma firm Duchesnay, based in Quebec.

© HealthDay

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Drug Fights Antibiotic-Resistant Infection

Saturday, 20 Dec 2014 10:33 AM

Cubist Pharmaceutical drug to treat complicated urinary tract and intra-abdominal infections won U.S. approval on Friday . . .

New Help Against Ovarian Cancer

Friday, 19 Dec 2014 15:48 PM

The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to ide . . .

Device Makes Blood Transfusions Safer

Wednesday, 17 Dec 2014 13:08 PM

U.S.health regulators on Tuesday approved a device developed by Cerus to reduce the risk of infections in blood plasma t . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved